Literature DB >> 15644862

Two for the price of one?

Mike Wyllie1.   

Abstract

Mesh:

Substances:

Year:  2005        PMID: 15644862      PMCID: PMC1575981          DOI: 10.1038/sj.bjp.0706038

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  5 in total

1.  Selective interactions between prostate fibroblast and epithelial cells in co-culture maintain the BPH phenotype.

Authors:  C W Bayne; M Ross; F Donnelly; K Chapman; C Buck; P Bollina; F K Habib
Journal:  Urol Int       Date:  1998-10       Impact factor: 2.089

Review 2.  Doxazosin and terazosin suppress prostate growth by inducing apoptosis: clinical significance.

Authors:  Natasha Kyprianou
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

3.  Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: meta-analysis of randomized clinical trials.

Authors:  P Boyle; A L Gould; C G Roehrborn
Journal:  Urology       Date:  1996-09       Impact factor: 2.649

4.  Angiotensin II-mediated calcium signals and mitogenesis in human prostate stromal cell line hPCPs.

Authors:  Gunther Wennemuth; Gerhard Aumüller
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

5.  The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.

Authors:  John D McConnell; Claus G Roehrborn; Oliver M Bautista; Gerald L Andriole; Christopher M Dixon; John W Kusek; Herbert Lepor; Kevin T McVary; Leroy M Nyberg; Harry S Clarke; E David Crawford; Ananias Diokno; John P Foley; Harris E Foster; Stephen C Jacobs; Steven A Kaplan; Karl J Kreder; Michael M Lieber; M Scott Lucia; Gary J Miller; Mani Menon; Douglas F Milam; Joe W Ramsdell; Noah S Schenkman; Kevin M Slawin; Joseph A Smith
Journal:  N Engl J Med       Date:  2003-12-18       Impact factor: 91.245

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.